Adachi M, Mita S, Obana M, Matsuoka Y, Harada K, Irimajiri S
Department of Internal Medicine, Kawasaki Municipal Hospital, Japan.
Jpn J Med. 1990 Sep-Oct;29(5):481-6. doi: 10.2169/internalmedicine1962.29.481.
In order to detect diagnostic clues to identify patients with chronic immune thrombocytopenia which is likely to develop systemic lupus erythematosus (SLE), a retrospective study was conducted. Of 39 patients with chronic immune thrombocytopenia, 4 fulfilled the diagnostic criteria being between 4.5 and 14 years after the initial diagnosis of "idiopathic" thrombocytopenic purpura. The remaining 35 patients were found to be idiopathic thrombocytopenic purpura (ITP) after at least a 5-year follow-up. It was noted that in patients with SLE who had thrombocytopenia at presentation, only 4 or 5 findings of diagnostic criteria were observed. Of particular interest, all patients who developed SLE were positive for anti-SS-A antibody, in contrast none of the patients with ITP had this antibody. Furthermore, despite the few clinical manifestations, we noted lupus peritonitis in 1 patient and pulmonary hypertension in another patient. In conclusion, the anti-SS-A antibody is an excellent clue for the early detection of SLE occurring as "idiopathic" thrombocytopenic purpura.
为了探寻诊断线索,以识别可能发展为系统性红斑狼疮(SLE)的慢性免疫性血小板减少症患者,我们开展了一项回顾性研究。在39例慢性免疫性血小板减少症患者中,4例在初次诊断“特发性”血小板减少性紫癜后的4.5至14年间符合SLE诊断标准。其余35例患者在至少5年的随访后被确诊为特发性血小板减少性紫癜(ITP)。值得注意的是,在初发时伴有血小板减少症的SLE患者中,仅观察到4或5项诊断标准中的表现。特别有趣的是,所有发展为SLE的患者抗SS - A抗体均呈阳性,相比之下,ITP患者中无一例有此抗体。此外,尽管临床表现较少,但我们注意到1例患者出现狼疮性腹膜炎,另1例患者出现肺动脉高压。总之,抗SS - A抗体是早期发现以“特发性”血小板减少性紫癜形式出现的SLE的极佳线索。